The FDA-approved facilities in the US, will manufacture Live Young Naturals product line. Hokutou CEO Eugene Collins said 70% of US adults use dietary supplements, and over $30bn
As part of the acquisition, the tendered shares were also transferred to BASF. In addition, BASF is setting up a compulsory acquisition process (squeeze out) to acquire the
The firm is planning to sell the shares through its wholly-owned subsidiary Elan Science Three and is expected to close the deal on 6 February 2013. Elan through
The scalability solution has become a major concern with over 10,000 lines to be serialized within the life sciences industry over the next 5 years, according to the
As part of the appraisal, NICE has issued a ‘Minded Not to Recommend’ and requested for the further information and analysis on the submitted cost-effectiveness model. Used as
Lennon will take the responsibility of firm’s global business development plans and work with the European and North American management teams. Lennon joined Clondalkin in 2009 as CEO
The collaboration, which forms part of MagForce’s new vision to conduct early-stage research and development with academic institutions, will form a more efficient magnetic fluid and a pilot
The patent is related to a system and method for submitting claims for a dispensed medication to a patient by point-of-care physicians. The USPTO said Targeted Medical will
Cetac is involved in providing sample handling and introduction products including autosamplers, autodilutors, liquid handling platforms and sample preparation stations to pharmaceutical, life sciences, clinical/forensic and separation sciences,
Teva, which entered into agreements with CureTech in 2006, intends to book a noncash net charge of $109m as a result of the impairment of its investment in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.